2015
DOI: 10.1016/j.neubiorev.2015.04.022
|View full text |Cite
|
Sign up to set email alerts
|

CACNA1C rs1006737 genotype and bipolar disorder: Focus on intermediate phenotypes and cardiovascular comorbidity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
29
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(29 citation statements)
references
References 83 publications
(99 reference statements)
0
29
0
Order By: Relevance
“…Previous studies have linked this haplotype to changes in CACNA1C expression, with decreases reported in brain (Gershon et al, 2014) and increases reported in cultured neurons (Yoshimizu et al, 2015). Brain imaging studies of CACNA1C show a variety of results that vary with the specific measure and brain region (Ou et al, 2015). The lack of consensus in findings is not necessarily surprising.…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies have linked this haplotype to changes in CACNA1C expression, with decreases reported in brain (Gershon et al, 2014) and increases reported in cultured neurons (Yoshimizu et al, 2015). Brain imaging studies of CACNA1C show a variety of results that vary with the specific measure and brain region (Ou et al, 2015). The lack of consensus in findings is not necessarily surprising.…”
Section: Discussionmentioning
confidence: 99%
“…Cell sizes (averaging 19.2 subjects) are shown in Table S1. The grouping of genotype groups had the purpose of maximising counterbalance for the rs1006737 CACNA1C SNP, as commonly practiced in the literature (Backes et al ; Dietsche et al ; Nieratschker et al ; Ou et al ; Woon et al ) given the much lower frequency counts of allele A, compared to C, in the Caucasian population. The SNPs reported in this manuscript are the only SNPs analysed in this imaging data set.…”
Section: Methodsmentioning
confidence: 99%
“…[15][16][17][18] CACNA1C encodes the α1C subunit of the voltage-gated L-type calcium ion (Ca 2+ ) channel Ca v 1.2. 19 CACNA1C is ranked as a prime candidate susceptibility gene, [20][21][22] most notably because single-nucleotide polymorphisms (SNPs) within CACNA1C belong to the best replicated and most robust genetic findings from genome-wide association studies in psychiatry. Ca v 1.2 accounts for~90% of all voltage-gated L-type Ca 2+ channels in the brain and represents a promising therapeutic target.…”
mentioning
confidence: 99%
“…Ca v 1.2 accounts for~90% of all voltage-gated L-type Ca 2+ channels in the brain and represents a promising therapeutic target. 19 CACNA1C is ranked as a prime candidate susceptibility gene, [20][21][22] most notably because single-nucleotide polymorphisms (SNPs) within CACNA1C belong to the best replicated and most robust genetic findings from genome-wide association studies in psychiatry. [23][24][25] Further evidence from clinical studies links rs1006737, the primary CACNA1C risk allele associated with neuropsychiatric disorders, to alterations in brain structure and function, both in patients [26][27][28][29] and healthy individuals.…”
mentioning
confidence: 99%